TCGL:NYSEMKTTechCreate Group Ltd. Analysis
Data as of 2026-05-04 - not real-time
$172.84
Latest Price
8/10Risk
Risk Level: High
Executive Summary
The stock trades at $172.84, exactly on its 20‑day and 50‑day SMA, but technical signals are exhausted – RSI 99.6 signals a severe overbought condition and the MACD has turned bearish with a negative histogram, while price rests on a flat support/resistance level, limiting upside.
Fundamentally the company is in distress: gross margin 36.7% but operating margin -36.7% and profit margin -22.4%, EBITDA and cash flows are deeply negative, and ROE is -17.9%. The balance sheet shows a staggering price‑to‑book of 4,410× and price‑to‑sales of 740×, far above the industry PE average of 38.2, marking the stock as dramatically overvalued. A newly announced securities class‑action investigation adds legal and reputational risk, and the extreme‑greed market sentiment (Fear & Greed Index 88.61) warns that the rally may be unsustainable.
Fundamentally the company is in distress: gross margin 36.7% but operating margin -36.7% and profit margin -22.4%, EBITDA and cash flows are deeply negative, and ROE is -17.9%. The balance sheet shows a staggering price‑to‑book of 4,410× and price‑to‑sales of 740×, far above the industry PE average of 38.2, marking the stock as dramatically overvalued. A newly announced securities class‑action investigation adds legal and reputational risk, and the extreme‑greed market sentiment (Fear & Greed Index 88.61) warns that the rally may be unsustainable.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- RSI at 99.6 indicating extreme overbought condition
- Bearish MACD divergence with negative histogram
- Ongoing securities class‑action investigation
Medium Term
1–3 yearsCautious
Model confidence: 7/10
Key Factors
- Massive overvaluation (PB 4,410×, PS 740×)
- Negative profitability and cash flow
- High beta (-2.38) suggesting amplified market swings
Long Term
> 3 yearsCautious
Model confidence: 6/10
Key Factors
- Sustained negative earnings and cash generation
- Legal risk from class‑action probe
- Lack of credible growth catalysts despite quantum‑safe POS collaboration
Key Metrics & Analysis
Financial Health
Revenue Growth110.10%
Profit Margin-22.44%
ROE-17.86%
ROA-8.33%
Debt/Equity2.69
P/B Ratio4410.6
Op. Cash Flow$-5031822
Free Cash Flow$-2149260
Industry P/E38.3
Technical Analysis
TrendNeutral
RSI99.6
Support$172.84
Resistance$172.84
MA 20$172.84
MA 50$172.84
MA 200$84.40
MACDBearish
VolumeStable
Fear & Greed Index88.61
Valuation
GradeOvervalued
TypeValue
Risk Assessment
Beta-2.39
0Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.